Navigation Links
NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease
Date:5/13/2008

NEW YORK (May 13, 2008) -- Promising results from a team of NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists show that gene therapy is both safe and effective at slowing the progression of Batten disease, or Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL), a rare, genetic, degenerative neurological disorder that usually becomes fatal in children by the age of 8 to 12.

The clinical trial found that the procedure -- which involves injecting a harmless gene-bearing virus into the brain -- was not only safe, but, on the average, significantly slowed the disease progression of the subjects tested. Neurological function was assessed using a rating scale throughout an 18-month follow-up period.

"The virus is used as a Trojan horse that houses and then delivers a healthy, functional gene into the cells of the brain," says lead author Dr. Ronald Crystal, chairman of the Department of Genetic Medicine and chief of the Division of Pulmonary and Critical Care Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "The genes are incorporated within the genetic material of the cells, which are then able to produce a protein that is deficient in Batten disease."

Dr. Crystal is a world leader and pioneer in the use of gene therapy to treat a number of genetic disorders and diseases.

The results are published in the May 13 online issue of Human Gene Therapy.

The gene in question -- CLN2 -- is mutated in children with the disease, causing a deficiency in the enzyme TTP-1, which is responsible for ridding cells of the central nervous system of waste materials. Small organelles within the cell, called lysosomes, become clogged with toxic material within the neurons of the brain.

"It's like the garbage man of the cell is not able to do its job," says Dr. Crystal. "The trash keeps getting backed up inside the cell until the cells can no longer function properly and then eve
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008
2. Weill Cornell receives funding to study creation of new elder abuse center
3. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
4. $50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center
5. By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis
6. NewYork-Presbyterian/Weill Cornell creates world-class cancer center
7. Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
8. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
9. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
10. Healthy restaurants help make us fat, says a new Cornell study
11. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...swire-USNewswire/ -- Preventing disease is the goa...ery year, new vaccines are being added to assist i...munity for the same period of time? And, if not, w...immunity strong? ,, In this month,s issue of ... Pediatrics, Michael Pichichero MD, Director of th...
(Date:11/27/2009)...l, economic burdens, study predicts , , ...people with diabetes in the United States is expec...predicts. , That would bring the total by 2034 ...from 23.7 million today. , , At the same time, t...le, the study also warns, rising from an estimated...
(Date:11/27/2009)...tive anatomy education apps from Modality and Lipp...es learning opportunities for iPhone and iPod touc...vember 27, 2009 -- Modality, Inc. and Lippincott...rs Kluwer Health, today announced the availability...ore. Clemente’s Anatomy, Rohen’s Photo...
(Date:11/26/2009)...d to strains or worse , , THURSDAY, Nov.... with stuffing your turkey full to bursting, but y...uitcase as you pack for holiday trips. , More t...pital emergency rooms, doctors, offices, clinics a...juries, such as muscle strains, pulls and tears, a...
(Date:11/26/2009)...ions announces a highly effective and unconvention... to make an economic recovery. , ...the type of challenge that could send ailing holid...avid Benton, business growth expert and author of ... The Rfactor Intensive . “Fear is one of t...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...r are diagnosed in the United States annually, and... // as small cell lung carcinoma (SCLC). Prognosis...ently travels to the brain and central nervous sys...ity from the disease, however, has been unclear. R...
...men between 20 and 34 years old. Advances in chemo...d survival rate from the cancer, but since men who...ffect of the cancer and its treatment on fertility...ggested the need for more study. Researchers looke...
...mon form of cancer in the United States. According... provide protection against colon cancer. In addit...size of tumors that develop. Investigators fed ...Diet one contained milk protein, and diet two had ...
...s , or who took the drugs for at least 501 days --...cer over an average of about 17 years, compared wi...d. Also, since antibiotics are widely used to t...drugs were unusually healthy and therefore unusual...
...n women ranges from 10 percent to 25 percent, with...bearing years. Some reports suggest as many as 14 ...nd up to 35 percent of women use antidepressants d...prescribed for pregnant women. However, most of th...
...examination by women are among two medical screeni...f these tests has been scientifically proven to re...predict mortality from prostate cancer among men k...never develop to the point of causing real problem...
Other Medicine News:
(Date:11/25/2009)...LTHAM, Mass., Nov. 25 According to...rity on medical technology market intelligence, th...devices will continue to see rapid growth over the...own. MRG,s US Markets for Trauma Devices 2010 ...ynamic over the next five years, with competitors ...
(Date:11/25/2009)...ELFT, The Netherlands and JOHANNESBURG, November 2... division and Pyxis Discovery announced today,that...ntly market both,companies, services. , P...d discovery expertise,will be coupled with iThemba...etic chemistry support to projects identified thro...
(Date:11/24/2009)...Calif., Nov. 24 Endologi...nvasive treatments for aortic disorders, announced...ontinue all proceedings in, the patent infringemen...ok, Inc. The motion was filed in the United State...ndologix has requested that the stay remain in eff...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Fourth Annual Capitol Classic Bike Race for Autism Awareness 52403 1Fourth Annual Capitol Classic Bike Race for Autism Awareness 52403 2NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism 3A Fragile X 52398 1NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism 3A Fragile X 52398 2Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R 26D Factbook 13145 1Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R 26D Factbook 13145 2
...in collaboration with the Centro de,Investigaci&oa...sity of Navarra, Pamplona, Spain, is being present...m, the Netherlands. , AMSTERDAM, the Netherlands, ... (AMT), a leader in the field of human gene therap...020 gene therapy to,treat acute intermittent porph...
...SINESS WIRE)--May 1, 2007 - Progenics,Pharmaceutic...results from the first clinical trial of its inves...with the human immunodeficiency,virus (HIV), the c...e 5.0 mg/kg dose of PRO 140 achieved an average ma...d of 98.5% (1.83,log10), with individual reduction...
Other Medicine Technology:Amsterdam Molecular Therapeutics BV to present preclinical,proof-of-concept data on its gene therapy AMT-020 to treat acute,intermittent porphyria 2Amsterdam Molecular Therapeutics BV to present preclinical,proof-of-concept data on its gene therapy AMT-020 to treat acute,intermittent porphyria 3Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 2Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 3Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 4Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 5Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 6Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 7
Terry-Schanzlin Astigmatome - Speculum Sets
...l Temporary Pacing Lead is designed to provide the...sing and pacing capabilities of the Medtronic Mode...treamline Temporary Pacing Leads are designed to p...ing and after cardiac surgery. Different models we...
...y of temporary sensing and pacing leads. Our engin...ing leads and improved upon the features that make...ue. , ,The Model 6491 Unipolar Pediatric Tempo...and ventricular sensing and pacing during and afte...
Carpentier-Edwards Classic Mitral Annuloplasty Rings
Medicine Products: